Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist | LCUKRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -11.4 | 18.3 | 1.2 | 7.5 | 3.3 | |
+/-Cat | -2.3 | 0.4 | 3.3 | -0.7 | 0.0 | |
+/-B’mrk | - | - | - | -0.1 | -0.2 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
Closing Price 29/04/2024 | GBX 1143.80 | |
Day Change | 0.77% | |
Morningstar Category™ | UK Large-Cap Equity | |
Volume | 37251 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1781541096 | |
Fund Size (Mil) 26/04/2024 | GBP 395.45 | |
Share Class Size (Mil) 26/04/2024 | GBP 395.45 | |
Ongoing Charge 10/02/2023 | 0.04% |
Investment Objective: Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist | LCUK |
The investment objective of the Sub-Fund is to track both the upward and the downward evolution of the Morningstar UK NR Index (the "Index") denominated in GBP and representative of the United Kingdom’s large and mid cap equity market - while minimizing the volatility of the difference between the return of the Sub-Fund and the return of the Index (the “Tracking Error”). The anticipated level of the tracking error under normal market conditions is expected to be up to 0.50%. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Armine Matevosyan 27/02/2018 | ||
Raphaël Dieterlen 27/02/2018 | ||
Inception Date 27/02/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Morningstar UK NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist | LCUK | 25/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Shell PLC | Energy | 8.66 |
AstraZeneca PLC | Healthcare | 8.59 |
HSBC Holdings PLC | Financial Services | 5.82 |
Unilever PLC | Consumer Defensive | 4.71 |
BP PLC | Energy | 4.16 |
Increase Decrease New since last portfolio | ||
Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist | LCUK |